# Effects of Yangxinshi Pills on the Exercise Tolerance Compared With Trimetazidine in Patients After PCI

> **NCT03809273** · PHASE4 · COMPLETED · sponsor: **Shenyang Northern Hospital** · enrollment: 681 (actual)

## Conditions studied

- Percutaneous Coronary Intervention

## Interventions

- **DRUG:** Yangxinshi
- **DRUG:** Trimetazidine
- **DRUG:** Yangxinshi mimic
- **DRUG:** Trimetazidine mimic

## Key facts

- **NCT ID:** NCT03809273
- **Lead sponsor:** Shenyang Northern Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 681 (ACTUAL)
- **Last updated:** 2025-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03809273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03809273, "Effects of Yangxinshi Pills on the Exercise Tolerance Compared With Trimetazidine in Patients After PCI". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03809273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*